| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 751.27M | 751.27M | 551.19M | 444.18M | 451.15M | 318.21M |
| Gross Profit | 578.05M | 578.05M | 400.06M | 43.54M | 311.85M | 221.55M |
| EBITDA | 56.98M | 56.98M | 43.11M | 32.50M | 32.54M | 27.28M |
| Net Income | 35.37M | 35.37M | 19.26M | 13.41M | 13.56M | 13.35M |
Balance Sheet | ||||||
| Total Assets | 470.97M | 470.97M | 288.15M | 227.42M | 231.98M | 155.56M |
| Cash, Cash Equivalents and Short-Term Investments | 94.32M | 94.32M | 100.97M | 46.74M | 27.88M | 34.18M |
| Total Debt | 51.74M | 51.74M | 29.25M | 27.73M | 27.17M | 19.88M |
| Total Liabilities | 311.19M | 311.19M | 166.98M | 122.44M | 138.56M | 97.85M |
| Stockholders Equity | 159.78M | 159.78M | 121.17M | 104.98M | 93.42M | 57.71M |
Cash Flow | ||||||
| Free Cash Flow | 107.82M | 107.82M | 68.90M | 32.09M | 6.60M | -4.30M |
| Operating Cash Flow | 120.93M | 120.93M | 82.84M | 37.79M | 11.47M | 6.99M |
| Investing Cash Flow | -46.36M | -46.36M | -15.82M | -7.31M | -24.25M | -12.42M |
| Financing Cash Flow | -16.21M | -14.72M | -12.79M | -11.48M | 6.33M | -189.08K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | AU$1.17B | 32.78 | 25.18% | 0.57% | 36.30% | 82.20% | |
71 Outperform | AU$726.70M | 20.92 | 50.61% | 5.24% | 12.96% | 8.19% | |
69 Neutral | AU$825.59M | 19.35 | 8.35% | 4.17% | -21.57% | -34.09% | |
66 Neutral | AU$1.90B | 37.69 | 13.62% | 1.85% | 23.76% | 21.18% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
GenusPlus Group Ltd has issued 396,721 new unquoted performance rights under its employee incentive scheme, with an expiry date of 1 July 2029. The move underscores the company’s continued use of equity-based incentives to align employees’ interests with long-term shareholder value, potentially strengthening staff retention and engagement without immediate dilution of quoted share capital.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$7.50 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has issued 396,721 performance rights to key management personnel and employees under its Employee Securities Incentive Plan, reinforcing its use of equity-linked incentives to align staff rewards with long-term shareholder outcomes. The rights, granted for no upfront consideration, are subject to performance hurdles based on absolute total shareholder return between July 2025 and June 2028 and continued employment, and may be settled either in shares or cash at the board’s discretion, a structure that could impact future dilution and remuneration outcomes while tying executive incentives closely to the company’s market performance.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$7.50 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has applied to the ASX for quotation of 62,240 new fully paid ordinary shares under its employee incentive scheme. The newly issued securities are not subject to transfer restrictions, indicating the company is continuing to use equity-based remuneration to incentivise staff and align employee interests with shareholder value, although the small number of shares suggests a limited impact on overall capital structure.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$7.50 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has secured a new A$429 million secured revolving syndicated facility with Commonwealth Bank of Australia, HSBC and National Australia Bank, replacing its previous A$147 million club facility. The three-year multi-option facility significantly expands the company’s funding capacity, providing greater financial flexibility to support its ongoing growth strategy amid favourable industry conditions, and, together with existing surety bond facilities, creates substantial headroom for future expansion and capital needs.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$7.50 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has confirmed the commencement of construction for the Hunter-Central Coast Renewable Energy Zone sub-transmission line works, following the execution of a Project Deed with Ausgrid and the Energy Corporation of New South Wales. The contract, valued at approximately $140 million, involves significant infrastructure upgrades, including the demolition and construction of sub-transmission lines and the installation of advanced communication cables, with completion expected by Q1 2028. This project positions GenusPlus as a key player in supporting renewable energy infrastructure in Australia.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$7.50 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd, in partnership with ACCIONA, has been awarded a significant contract by AusNet to construct the Western Renewables Link in Victoria, valued at approximately AUD$1.6 billion. This project, which aims to enhance Victoria’s renewable energy infrastructure, will involve the construction of a 500 kV transmission line and is expected to generate substantial economic and community benefits, including job creation and long-term advantages for the local economy.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd. has announced a change in the director’s interest notice involving David William Riches. The change involves the acquisition of 357,277 fully paid ordinary shares valued at $1,800,000 as contingent consideration for the acquisition of shares in Partum Engineering Pty Ltd. This transaction reflects a strategic move by GenusPlus to consolidate its interests, potentially impacting its operational dynamics and stakeholder relationships.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd announced the release of 2,460,937 fully paid ordinary shares from voluntary escrow, linked to its acquisition of Partum Engineering Pty Ltd. This release signifies a strategic move following the acquisition, with 357,277 shares remaining under escrow until December 2026, potentially impacting shareholder value and market perception.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has announced the quotation of 357,277 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of December 1, 2025. This move is part of a previously announced transaction, potentially enhancing the company’s market presence and providing additional liquidity for stakeholders.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has announced the appointment of Tony Narvaez as a director, effective from November 21, 2025. The Initial Director’s Interest Notice reveals that Tony Narvaez currently holds no relevant interests in securities, either as a registered holder or otherwise, and has no interests in contracts related to the company. This announcement is part of the company’s compliance with ASX listing rules, ensuring transparency in its governance practices.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd. held its Annual General Meeting on November 20, 2025, where several key resolutions were voted on. The meeting resulted in the approval of the remuneration report, the re-election of director Simon High, and the issuance of contingent consideration shares to David Riches and Matthew Riches under the Partum transaction. These outcomes reflect strong shareholder support for the company’s current management and strategic direction.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd held its 2025 Annual General Meeting, highlighting a record year with a Total Shareholder Return of 101% and a significant increase in cash position. The company announced the addition of Tony Narvaez to its board, whose expertise in energy and infrastructure is expected to enhance the company’s strategic direction and strengthen its ability to deliver long-term value.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has appointed Tony Narvaez as a Non-Executive Independent Director, effective November 21, 2025. With extensive experience in the energy sector, including leadership roles at AusNet Services and other major energy companies, Narvaez is expected to bring valuable insights to GenusPlus. His appointment is anticipated to bolster the company’s strategic direction in the energy and infrastructure sectors, particularly as the industry undergoes rapid transformation with increasing opportunities in renewables and advanced technologies.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd. has announced the issuance of 131,207 fully paid ordinary securities to be quoted on the Australian Securities Exchange (ASX). This move, part of an employee incentive scheme, reflects the company’s strategy to enhance employee engagement and align their interests with shareholders. The issuance may strengthen GenusPlus Group’s market position by potentially increasing liquidity and demonstrating a commitment to rewarding its workforce.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has announced the cessation of certain securities, specifically 93,376 performance rights and 99,708 share appreciation rights. These securities have lapsed due to the conditions not being met or becoming incapable of being satisfied, which may impact the company’s capital structure and investor perceptions.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has released its corporate governance statement for the financial year ending 30 June 2025, which is available on their website. The statement confirms compliance with the ASX Corporate Governance Council’s principles and recommendations, detailing the company’s adherence to governance practices and outlining any deviations. This disclosure is significant for stakeholders as it provides transparency into the company’s governance framework and practices, potentially impacting investor confidence and the company’s market positioning.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has announced a proposed issue of 357,277 fully paid ordinary securities, with the issue date set for November 26, 2025. This move is part of the company’s strategy to enhance its capital structure, potentially impacting its market positioning and offering new opportunities for stakeholders.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has announced its Annual General Meeting (AGM) scheduled for 20 November 2025, to be held in Perth, Western Australia. Shareholders can participate by attending in person or voting by proxy, with the company encouraging active participation. This meeting is significant for stakeholders as it provides an opportunity to engage with the company’s board and discuss resolutions, reflecting GenusPlus Group’s commitment to transparency and shareholder involvement.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has been awarded three significant contracts by Fortescue Metals Group as part of Fortescue’s decarbonisation initiatives in Western Australia. The contracts, valued at approximately $60 million, involve the construction of transmission lines and power distribution infrastructure at Fortescue’s mining sites, with completion expected by the fourth quarter of 2026. This collaboration underscores GenusPlus’s ongoing commitment to supporting Fortescue’s efforts to achieve Real Zero terrestrial emissions by 2030, enhancing its position as a key player in the power and communications infrastructure industry.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has been awarded additional work under its contract with Western Power for the Clean Energy Link – North project, valued at approximately $50 million. This project aims to enhance the transmission network capacity in Western Australia to support renewable energy integration. Additionally, GenusPlus secured a $25 million contract for the Network Renewal Underground Power Pilot project, further strengthening its partnership with Western Power and reinforcing its position in the power infrastructure industry.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.